From a state oversight process that killed an ASC rather than saved it to the federal government’s largest ASC antitrust action in history, here are five controversies that every operator should know. 1. The Oregon ASC that regulators couldn’t save …
Search Results
Showing 844 results for “Page-2”
Selected filters:
Eric Evans is CEO and director of Surgery Partners, one of the largest ASC chains in the U.S.
Private equity interest in ASCs is growing. Here are 10 things to know about PE and ASCs:
Hospitals are under pressure to do three things at once. Keep doors open for injured patients. Improve revenue capture despite rising denials. Reduce downstream bad debt and write-offs. Nowhere is that tension sharper than in personal-injury care, where payment timing…
For nearly as long as health insurers have used prior authorization to control costs, physicians and hospitals have argued it does more harm than good. The pushback against prior authorization has reached new heights in recent months as healthcare leadership,…
ASCs are rapidly becoming the setting of choice for a growing share of surgical procedures, but as patient acuity rises and payment models shift, the anesthesia workforce is grappling with mounting pressures. Five anesthesia leaders joined Becker’s to discuss the…
The costs of doing business continue to soar for ASCs, while Medicare and private payer reimbursements continue to decrease.
Here are five issues anesthesia providers are watching as we begin 2025:
During a featured session at Becker's 21st Annual Spine, Orthopedic and Pain Management-Driven ASC +The Future of Spine Conference, Brett Spark, president of Aroris Health, discussed challenges and opportunities in payer contracting for ASCs.
While New York remains a hotspot for ASCs, housing 160 facilities, patients are beginning to move out of New York City in favor of less expensive cities nationwide, according to an Aug. 8 report from CNBC based on a StreetEasy…
